Norges Bank

Company

Related News

Institutional Investors Adjust AbbVie Stakes as Stock Trades Near Highs, Analysts Raise Targets

Jul 25, 2026

Institutional investors disclosed major changes to their AbbVie holdings as the stock hovers near record levels. AbbVie maintains a Moderate Buy analyst consensus with a $268.10 price target, buoyed by strong quarterly earnings and a newly declared dividend.

Moderna Reports Q4 Revenue of $678M, FDA to Review mRNA Flu Vaccine

Mar 21, 2026

Moderna reported Q4 revenues of $678 million, down 29.8% year-over-year but beating analyst expectations. The FDA reversed course and will review the company's mRNA flu vaccine application.